Annals of Surgical Oncology

, Volume 4, Issue 4, pp 328–333 | Cite as

Low-risk differentiated thyroid cancer: The need for selective treatment

  • Ashok R. Shaha
  • Jatin P. Shah
  • Thom R. Loree
Original Articles


Background: The well recognized prognostic factors in differentiated carcinoma of the thyroid are age, grade, extracapsular extension, distant metastasis, and size of the tumor. Based on these prognostic factors, we have divided patients into low-, intermediate-, and high-risk categories. Clearly, there are significant differences in these three groups. This article analyzes in depth our data on low-risk thyroid cancer patients.

Methods: A retrospective review of 1,038 patients with differentiated carcinoma of the thyroid was undertaken. Various prognostic factors and risk groups were analyzed. Univariate and multivariate analyses were performed, and the survival curves were plotted by the Kaplan-Meier method. The inclusion criteria for the low-risk group were age younger than 45 years, tumors <4 cm in size, low-grade histology, absence of distant metastasis, and absence of extrathyroidal extension. There were 465 patients in the low-risk group. Four hundred three patients had papillary and 62 patients had follicular thyroid cancer. There were 120 male and 354 female patients. Two hundred seventy-eight patients (60%) presented with clinically apparent lymph node metastasis.

Results: With a median follow-up of 20 years, the 10- and 20-year survival in this select group was 99%. The local, regional, and distant recurrence rates were 5, 9, and 2% in this series. The analysis of the data showed statistical difference in local recurrence rate between partial lobectomy and total lobectomy (27 vs. 4%; p=0.005). There was no statistical difference in local recurrence rate between total lobectomy compared with total thyroidectomy (4 vs. 1%; p=0.10). The overall failure rate between partial lobectomy and total thyroidectomy (27 vs. 8%) was statistically significant (p=0.04). There was no statistical difference in the overall failure rate between total lobectomy and total thyroidectomy (13 vs. 8%; p=0.06). There was no survival difference between various histologies or nodal status.

Conclusions: Patients with low-risk tumors have excellent long-term survival. Nodulectomy or partial lobectomy should be avoided. The intraoperative decisions regarding the extent of thyroidectomy should be based on gross clinical findings and risk group analysis.

Key Words

Thyroid cancer Prognostic factors Risk groups Surgical treatment 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics.CA 1996;46:5–27.PubMedGoogle Scholar
  2. 2.
    Hay ID, Grant CS, Taylor WF, McConahey WM. Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: a retrospective analysis of surgical outcome using a novel prognostic scoring system.Surgery 1987;102:1088–95.PubMedGoogle Scholar
  3. 3.
    Cady B, Ross R, Silverman M, Wool M. Further evidence of the validity of risk-group definition in differentiated thyroid gland.Surgery 1985;98:1171–8.PubMedGoogle Scholar
  4. 4.
    Shah J, Loree TR, Dharker D, Strong EW, Begg C, Vlamis V. Prognostic factors in differentiated carcinoma of the thyroid gland.Am J Surg 1992;164:658–61.PubMedGoogle Scholar
  5. 5.
    Cady B, Sedgwick CE, Meissner WA, Wool MS, Salzman FA, Werber J. Risk factor analysis in differentiated thyroid cancer.Cancer 1979;43:810–9.PubMedGoogle Scholar
  6. 6.
    Hay ID, Bergstralh EJ, Goellner JR, et al. Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989.Surgery 1993;114:2050–8.Google Scholar
  7. 7.
    Cady B, Rossi R. An expanded view of risk group definition in differentiated thyroid carcinoma.Surgery 1988;104:947–53.PubMedGoogle Scholar
  8. 8.
    Shaha A, Loree TR, Shah JP. Intermediate risk group for differentiated carcinoma of the thyroid.Surgery 1994;116:1036–42.PubMedGoogle Scholar
  9. 9.
    Simpson WJ, McKinney SE, Carruthers JS, et al. Papillary and follicular thyroid cancer: prognostic factors in 1,578 patients.Am J Med 1987;83:479–88.CrossRefPubMedGoogle Scholar
  10. 10.
    Jossart GH, Clark OH. Well differentiated thyroid cancer.Curr Prob Surg 1994;31:935–1011.Google Scholar
  11. 11.
    Byar DP, Green SB, Dor P, et al. A prognostic index for thyroid carcinoma. A study of the E.O.R.T.C. Thyroid Cancer Cooperative Group.Eur J Cancer 1979;15:1033–41.PubMedGoogle Scholar
  12. 12.
    Rosai J, Carcangiu ML, DeLellis RA.Tumors of the thyroid gland. Washington, D.C.: Armed Forces Institute of Pathology, 1992. (Atlas of tumor pathology; 3rd series).Google Scholar

Copyright information

© The Society of Surgical Oncology, Inc. 1997

Authors and Affiliations

  • Ashok R. Shaha
    • 1
  • Jatin P. Shah
    • 1
  • Thom R. Loree
    • 1
  1. 1.From the Head and Neck ServiceMemorial Sloan-Kettering Cancer CenterNew YorkUSA

Personalised recommendations